Chronic Q fever: Expert opinion versus literature analysis and consensus

Journal of Infection

Volumn 65, Issue 2, 2012, Pages 102-108

  Raoult, Didier ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Q fever

Indexed keywords

IMMUNOGLOBULIN G1 ANTIBODY;

ANTIBODY TITER; ARTICLE; CHRONIC DISEASE; CLINICAL FEATURE; COXIELLA BURNETII; DISEASE ASSOCIATION; ENDOCARDITIS; EPIDEMIC; EVIDENCE BASED MEDICINE; FOLLOW UP; HUMAN; INCIDENCE; NETHERLANDS; NOMENCLATURE; NONHUMAN; POLYMERASE CHAIN REACTION; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; Q FEVER; SCORING SYSTEM; SEROLOGY; VASCULAR DISEASE; VASCULAR INFECTION;

COMMUNICABLE DISEASE CONTROL; CONSENSUS; DISEASE OUTBREAKS; ENDOCARDITIS; EXPERT TESTIMONY; HISTOCYTOCHEMISTRY; HUMANS; NETHERLANDS; Q FEVER; RADIOGRAPHY, THORACIC; VASCULITIS;

EID: 84862976486     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2012.04.006     Document Type: Article

References (38)

1. Wegdam-Blans M.C., Kampschreur L.M., Delsing C.E., Bleeker-Rovers C.P., Sprong T., van Kasteren M.E., et al. Chronic Q fever: review of the literature and a proposal of new diagnostic criteria. J Infect 2012, 64(3):247-259.
2. Raoult D., Etienne J., Massip P., Iaocono S., Prince M.A., Beaurain P., et al. Q fever endocarditis in the south of France. J Infect Dis 1987, 155:570-573.
3. Raoult D., Urvolgyi J., Etienne J., Roturier M., Puel J., Chaudet H. Diagnosis of endocarditis in acute Q-fever by immunofluorescence serology. Acta Virol 1988, 32:70-74.
4. Maurin M., Raoult D. Q fever. Clin Microbiol Rev 1999, 12(4):518-553.
5. Raoult D., Marrie T., Mege J. Natural history and pathophysiology of Q fever. Lancet Infect Dis 2005, 5(4):219-226.
6. Hogema B.M., Slot E., Molier M., Schneeberger P.M., Hermans M.H., van Hannen E.J., et al. Coxiella burnetii infection among blood donors during the 2009 Q-fever outbreak in the Netherlands. Transfusion 2012, 52(1):144-150.
7. Glazunova O., Roux V., Freylikman O., Sekeyova S., Fournous G., Tyczka J., et al. Coxiella burnetii genotyping. Emerg Infect Dis 2005, 11(8):1211-1217.
8. Click E.S., Moonan P.K., Winston C.A., Cowan L.S., Oeltmann J.E. Relationship between Mycobacterium tuberculosis phylogenetic lineage and clinical site of tuberculosis. Clin Infect Dis 2012, 54(2):211-219.
9. Stein A., Louveau C., Lepidi H., Ricci F., Baylac P., Davoust B., et al. Q fever pneumonia: virulence of Coxiella burnetii pathovars in a murine model of aerosol infection. Infect Immun 2005, 73(4):2469-2477.
10. Russell-Lodrigue K.E., Andoh M., Poels M.W., Shive H.R., Weeks B.R., Zhang G.Q., et al. Coxiella burnetii isolates cause genogroup-specific virulence in mouse and guinea pig models of acute Q fever. Infect Immun 2009, 77(12):5640-5650.
11. Munster J.M., Steggerda L.M., Leenders A.C., Aarnoudse J.G., Hak E. Screening for Coxiella burnetii infection during pregnancy: pros and cons according to the Wilson and Jungner criteria. Euro Surveill 2012, 17(3):20061.
12. Tilburg JJ, Roest H-JIJ, Buffet S, Nabuurs-Franssen MH, Horrevorts AM, Raoult D, et al. Epidemic C. burnetii genotype, the Netherlands. Emerg Infect Dis, in press.
13. Angelakis E, D'Amato RF, Richet H, Roland JM, Raoult D. The strain specific effects of Coxiella burnettii on pregnancy in humans. Emerg Infect Dis, submitted for publication.
14. Leroy Q., Armougom F., Barbry P., Raoult D. Genomotyping of Coxiella burnetii using microarrays reveals a conserved genomotype for Hard Tick isolates. PLoS ONE 2011, 6(10):e25781.
15. Carcopino X., Raoult D., Bretelle F., Boubli L., Stein A. Managing Q fever during pregnancy: the benefits of long-term cotrimoxazole therapy. Clin Infect Dis 2007, 45(5):548-555.
16. Peacock M.G., Philip R.N., Williams J.C., Faulkner R.S. Serological evaluation of O fever in humans: enhanced phase I titers of immunoglobulins G and A are diagnostic for Q fever endocarditis. Infect Immun 1983, 41:1089-1098.
17. Raoult D., Houpikian P., Tissot-Dupont H., RISS J.M., Arditi-Djiane J., Brouqui P. Treatment of Q fever endocarditis: comparison of two regimens containing doxycycline and ofloxacin or hydroxychloroquine. Arch Intern Med 1999, 159(2):167-173.
18. Dupont H.T., Thirion X., Raoult D. Q fever serology: cutoff determination for microimmunofluorescence. Clin Diagn Lab Immunol 1994, 1(2):189-196.
19. Botelho-Nevers E., Fournier P.E., Richet H., Fenollar F., Lepidi H., Foucault C., et al. Coxiella burnetii infection of aortic aneurysms or vascular grafts: report of 30 new cases and evaluation of outcome. Eur J Clin Microbiol Infect Dis 2007, 26(9):635-640.
20. Fournier P.E., Casalta J.P., Habib G., Messana T., Raoult D. Modification of the diagnostic criteria proposed by the Duke endocarditis service to permit improved diagnosis of Q fever endocarditis. Am J Med 1996, 100(6):629-633.
21. Li J.S., Sexton D.J., Mick N., Nettles R., Fowler V.G.J., Ryan T., et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000, 30:633-638.
22. Frankel D., Richet H., Renvoise A., Raoult D. Q fever in France, 1985-2009. Emerg Infect Dis 2011, 17(3):350-356.
23. Healy B., van W.H., Raoult D., Graves S., Pitman J., Lloyd G., et al. Chronic Q fever: different serological results in three countries-results of a follow-up study 6 years after a point source outbreak. Clin Infect Dis 2011, 52(8):1013-1019.
24. Million M., Thuny F., Richet H., Raoult D. Long-term outcome of Q fever endocarditis: a 26-year personal survey. Lancet Infect Dis 2010, 10(8):527-535.
25. Raoult D., Million M., Thuny F., Carrieri P. Chronic Q fever detection in the Netherlands. Clin Infect Dis 2011, 53(11):1170-1171.
26. Fenollar F., Fournier P.E., Raoult D. Molecular detection of Coxiella burnetii in the sera of patients with Q fever endocarditis or vascular infection. J Clin Microbiol 2004, 42(11):4919-4924.
27. Raoult D. Being careful with PCR to avoid erroneous discoveries. Scand J Infect Dis 2011, 43(5):323-324.
28. Lepidi H., Houpikian P., Liang Z., Raoult D. Cardiac valves in patients with Q fever endocarditis: microbiological, molecular, and histologic studies. J Infect Dis 2003, 187(7):1097-1106.
29. Mesana T.G., Collart F., Caus T., Salamand A. Q fever endocarditis: a surgical view and a word of caution. J Thorac Cardiovasc Surg 2003, 125(1):217-218.
30. van der Hoek W., Schneeberger P.M., Oomen T., Wegdam-Blans M.C., Dijkstra F., Notermans D.W., et al. Shifting priorities in the aftermath of a Q fever epidemic in 2007 to 2009 in the Netherlands: from acute to chronic infection. Euro Surveill 2012, 17(3):20059.
31. Raoult D., Tissot-Dupont H., Foucault C., Gouvernet J., Fournier P.E., Bernit E., et al. Q fever 1985-1998-clinical and epidemiologic features of 1383 infections. Medicine 2000, 79(2):109-123.
32. Thuny F., Grisoli D., Collart F., Habib G., Raoult D. Management of infective endocarditis: challenges and perspectives. Lancet 2012, 379(9819):965-975.
33. Merhej V., Cammilleri S., Piquet P., Casalta J.P., Raoult D. Relevance of the positron emission tomography in the diagnosis of vascular graft infection with Coxiella burnetii. Comp Immunol Microbiol Infect Dis 2012, 35(1):45-49.
34. Marmion B.P., Storm P.A., Ayres J.G., Semendric L., Mathews L., Winslow W., et al. Long-term persistence of Coxiella burnetii after acute primary Q fever. QJM 2005, 98(1):7-20.
35. Limonard G.J., Nabuurs-Franssen M.H., Dekhuijzen P.N., Groot C.A. Prevention of Q fever endocarditis. Lancet Infect Dis 2011, 11(2):82-83.
36. Houpikian P., Habib G., Mesana T., Raoult D. Changing clinical presentation of Q fever endocarditis. Clin Infect Dis 2002, 34(5):E28-E31.
37. Kampschreur L.M., Dekker S., Hagenaars J.C., Lestrade P.J., Renders N.H., de Jager-Leclercq M.G., et al. Identification of risk factors for chronic Q fever, the Netherlands. Emerg Infect Dis 2012, 18(4):563-570.
38. Landais C., Fenollar F., Thuny F., Raoult D. From acute Q fever to endocarditis: serological follow-up strategy. Clin Infect Dis 2007, 44(10):1337-1340.